Brief: Cipher Pharmaceuticals Q1 loss per share $0.06 from continuing operations
11/05/2017 12:00
May 11 (Reuters) - Cipher Pharmaceuticals Inc CPH.TO
* Cipher pharmaceuticals reports q1 2017 financial results
* Q1 loss per share $0.06 from continuing operations
* Q1 revenue rose 18 percent to $8.1 million
* Q1 earnings per share view $0.01, revenue view $8.8
million -- Thomson Reuters I/B/E/S
Source text for Eikon: ID:nCNWXKXSTa
Further company coverage: CPH.TO
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Cipher Pharmaceuticals
See all newsBrief: Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award
Canada's Cipher Pharma Q2 revenue falls on lower Natroba sales amid reduced Medicaid coverage
Canada Research Roundup: Altius Minerals, Cipher Pharmaceuticals, Suncor Energy
Canada's Cipher Pharmaceuticals Q1 net income jumps 135% on lower costs
Brief: Cipher Pharmaceuticals Q1 Net Income USD 6.163 Million